RTW Investments’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

RTW Investments’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,389,705	Closed	-$17.1M	–	81
2022 Q4	$17.1M	Hold	1,389,705	–	–	0.35%	41
2022 Q3	$45.6M	Hold	1,389,705	–	–	1.05%	30
2022 Q2	$26.2M	Hold	1,389,705	–	–	0.68%	36
2022 Q1	$24.4M	Buy	+1,389,705	New	+$28.5M	0.5%	47

RTW Investments's CINC Position: Q1 2023 in Review

RTW Investments sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 1,389,705 shares — an estimated $17.1M sold.

RTW Investments first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $45.6M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

RTW Investments reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
RTW Investments sold 1,389,705 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $17.1M.
RTW Investments first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
RTW Investments's CinCor Pharma, Inc. Common Stock position peaked at $45.6M in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on RTW Investments's 13F filing for Q1 2023, filed 15 May 2023.